SCHEMBL484752

SCHEMBL484752

O=C(NC1CCc2ccc(C(=O)N3CCC4(CCN(CCCc5cccc(F)c5)CC4)CC3)cc21)c1cc(C(F)(F)F)ccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.44
CYP2D6 P10635 7/20 0.42
MAPK1 P28482 2/20 0.42
CRHR1 P34998 5/20 0.40
USP2 O75604 3/20 0.40
HTR1A P08908 2/20 0.39
DRD2 P14416 2/20 0.39
HTR2A P28223 2/20 0.39
KCNH2 Q12809 2/20 0.39
TSHR P16473 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 1/20 0.39
CRHR2 Q13324 2/20 0.38
RECQL P46063 1/20 0.36
CCR2 P41597 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484935 0.96 CYP3A4 (0.40) CYP3A4CYP2D6MAPK1CRHR1USP2
SCHEMBL484540 0.93 HTR1A (0.41) CYP3A4CYP2D6CRHR1USP2HTR1A
SCHEMBL484362 0.89 USP2 (0.46) CYP3A4CYP2D6MAPK1CRHR1USP2
SCHEMBL484853 0.89 DRD2 (0.41) CYP3A4CYP2D6CRHR1HTR1ADRD2
SCHEMBL484680 0.89 CYP2D6 (0.44) CYP3A4CYP2D6MAPK1USP2HTR1A
SCHEMBL485032 0.85 USP2 (0.42) CYP3A4CYP2D6CRHR1USP2HTR1A
SCHEMBL2819000 0.85 CYP3A4 (0.44) CYP3A4CYP2D6MAPK1CRHR1USP2
SCHEMBL485017 0.85 CYP2D6 (0.40) CYP3A4CYP2D6MAPK1USP2HTR1A
SCHEMBL2816409 0.85 CYP3A4 (0.43) CYP3A4CYP2D6MAPK1CRHR1USP2
SCHEMBL2816296 0.84 CYP3A4 (0.43) CYP3A4CYP2D6MAPK1CRHR1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885CYP2D6 1926/4885MAPK1 1001/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885CYP2D6 1926/4885MAPK1 1001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.